21 Sep

FDA seeks USPTO action to tackle patent thicketing

Department of Health recommendations to tackle perceived patent abuses that keep US drug prices high may not amount to much, but recent FDA proposals to the USPTO could be heading in the right direction

Adam Houldsworth

Author | Life sciences reporter

[email protected]

Adam Houldsworth